Rapid IO Signature Development
IO 360™ Panel
Faster than qPCR. Simpler than NGS.
Expertly Curated. Ready to Use.
New Cell Press Supplement
Pathological Mechanisms of Neurodegeneration
Small Sample. Big Insight.
nCounter® Analysis System
More insights from
Prosigna® Breast Cancer Prognostic Gene Signature Assay
Empowering personalized treatment decisions
Learn More *See product pages for regulatory status information
on actionable answers
Sergio Rutella, M.D., Ph.D., FRCPath is a Professor of Cancer Immunotherapy at the John van Geest Cancer Research Centre at Nottingham Trent University. His research focuses on acute myeloid leukemia (AML), an aggressive form of cancer that originates in the bone marrow. We recently spoke with Dr. Rutella about his research and the challenges of studying this disease.
Robin Lynn White
December 14, 2017
nCounter® Analysis in Complex Biology:
Gene expression profile predicts response to pembrolizumab
A video review of JCI publication by Ayers, et al:
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
Integrated Interrogation of Oncogenic Signaling Pathways, Immunology, and Heterogeneity in Cancer - FEB 22, 2018 9:30 AM PST (5:30 PM GMT)
LabRoots Drug Discovery 2018 Virtual Event
Michael A. Davies, M.D., Ph.D, Deputy Chairman and Associate Professor in the Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center
Examples of studies will be presented in which NanoString's Digital Spatial Profiling has been used to assess immune and molecular features to make insights into the pathogenesis of melanoma.
Deciphering the complexities of Neurodegeneration and Neuroinflammation with gene expression profiling - MAR 14, 2018 12:00 PM PST (8:00 PM GMT)
LabRoots Neuroscience 2018 Virtual Event
Kelly Miller, Ph.D., Field Applications Scientist, NanoString Technologies
In this webinar, we demonstrate the robust performance of the nCounter® Analysis platform for gene expression profiling of human post-mortem brain specimens, human blood samples and tissue from mouse models of neurodegenerative disease with an emphasis on performance and reproducibility in FFPE samples.
Challenges with gene expression profiling in a biotech setting and recent technical advances with NanoString PlexSet™ - Originally aired JAN 24, 2018
Matt Goddeeris, Principal Scientist, Mitobridge
Mitobridge has used NanoString PlexSet Reagents for gene expression, systematically interrogating disease-related changes in mitochondrial activity and translating unique insights into potential new treatments.